Acetic Acid

Acetic Acid

SCHEMBL7243728

CC(=O)[O-].CC(=O)[O-].CC(=O)[O-].COc1ccc(O)c(-c2ccc(-c3ccc(-c4ccccc4O)cn3)nc2)c1.[Mn+3]

nearest known ligand 0.45

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

ADRA2AADRA2BADRA2CADRB2AGTR1AVPR1AAVPR1BAVPR2BDKRB2CALCRCHRNA3CHRNB4ESR1ESR2GHSRGNRHRGSC1HSPA8MALT1MC1RMC4RNOS1NOS2NOS3OPRK1OXTRRAMP1RAMP2RAMP3SCN5ASSTR1SSTR2SSTR3SSTR4SSTR5dacAdacBdacCfolPftsImrcAmrcBmrdArplArplBrplCrplDrplErplFrplJrplKrplLrplMrplNrplOrplPrplQrplRrplSrplTrplUrplVrplWrplXrplYrpmArpmBrpmCrpmDrpmErpmFrpmGrpmHrpmIrpmJrpsArpsBrpsCrpsDrpsErpsFrpsGrpsHrpsIrpsJrpsKrpsLrpsMrpsNrpsOrpsPrpsQrpsRrpsSrpsTrpsUykgMykgO

The experimentally established mechanism targets of Acetic Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GAA P10253 6/20 0.45
SMN1; SMN2 Q16637 3/20 0.45
ALDH1A1 P00352 2/20 0.45
TSHR P16473 2/20 0.45
HTT P42858 1/20 0.45
NOD2 Q9HC29 1/20 0.45
KMT2A Q03164 9/20 0.44
RAB9A P51151 7/20 0.44
MEN1 O00255 7/20 0.44
NPC1 O15118 6/20 0.44
ALOX15 P16050 6/20 0.44
LMNA P02545 4/20 0.44
KDM4E B2RXH2 3/20 0.44
ALOX12 P18054 2/20 0.44
NFKB1 P19838 2/20 0.44
NFKB2 Q00653 2/20 0.44
RELA Q04206 2/20 0.44
MAPT P10636 6/20 0.43
HPGD P15428 4/20 0.43
NPSR1 Q6W5P4 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Acetic Acid SCHEMBL7233241 0.94 KMT2A (0.48) GAASMN1; SMN2ALDH1A1TSHRHTT
Hydrochloric Acid SCHEMBL7232788 0.91 NPC1 (0.49) GAASMN1; SMN2ALDH1A1TSHRKMT2A
SCHEMBL7772693 0.90 NPC1 (0.50) GAASMN1; SMN2ALDH1A1TSHRKMT2A
Acetic Acid SCHEMBL7235306 0.89 KMT2A (0.46) GAASMN1; SMN2ALDH1A1TSHRHTT
Acetic Acid SCHEMBL7235881 0.89 KMT2A (0.50) GAASMN1; SMN2ALDH1A1TSHRHTT
Acetic Acid SCHEMBL7242221 0.88 KMT2A (0.51) GAASMN1; SMN2ALDH1A1TSHRHTT
Acetic Acid SCHEMBL7235569 0.88 FYN (0.42) GAASMN1; SMN2ALDH1A1TSHRHTT
Acetic Acid SCHEMBL7233760 0.88 GAA (0.44) GAASMN1; SMN2ALDH1A1TSHRHTT
Acetic Acid SCHEMBL7239234 0.86 ALOX5AP (0.45) ALDH1A1RAB9ALMNAHPGD
Hydrochloric Acid SCHEMBL7234590 0.85 KMT2A (0.54) GAASMN1; SMN2ALDH1A1TSHRHTT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1119573-A2 BIPYRIDINE MANGANESE COMPLEXES EUKARION, INC. (US) 2001-08-01 EP claimed
US-6177419-B1 ANTIOXIDANT CHELATE COMPOUNDS FOR PREVENTING OXYGEN FREE RADICAL-ASSOCIATED DISEASES IN MAMMALS; NEUROPROTECTANTS, SUPEROXIDE DISMUTASE (SOD), CATALASE (CAT) AND/OR PEROXIDASE (POD) MIMETICS EUKARION, INC. 2001-01-23 US claimed
WO-2000009512-A2 BIPYRIDINE MANGANESE COMPLEXES EUKARION, INC. (US) 2000-02-24 WO claimed
US-6541490-B1 Treating ischemia or reoxygenation injury; preparation from a bipyridine, a benzeneboronic acid and a manganese salt EUKARION, INC. 2003-04-01 US disclosed
EP-1119573-A2 BIPYRIDINE MANGANESE COMPLEXES EUKARION, INC. (US) 2001-08-01 EP disclosed
US-6177419-B1 ANTIOXIDANT CHELATE COMPOUNDS FOR PREVENTING OXYGEN FREE RADICAL-ASSOCIATED DISEASES IN MAMMALS; NEUROPROTECTANTS, SUPEROXIDE DISMUTASE (SOD), CATALASE (CAT) AND/OR PEROXIDASE (POD) MIMETICS EUKARION, INC. 2001-01-23 US disclosed
WO-2000009512-A2 BIPYRIDINE MANGANESE COMPLEXES EUKARION, INC. (US) 2000-02-24 WO disclosed